| Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients (NCT01044654) | Sangamo Therapeutics | 2009-12-01 |
| Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding (NCT00640263) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-01 |
| Study of Bone Disease in Older HIV-infected Adults (NCT00935935) | Ruth M. Rothstein CORE Center | 2009-12-01 |
| Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients (NCT01039220) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-01 |
| Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status (NCT01040091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| HIV Persistence and Viral Reservoirs (NCT01025427) | University of California, San Francisco | 2009-12-01 |
| Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine (NCT00970879) | Institut de Recherche pour le Developpement | 2009-12-01 |
| Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users (NCT01108679) | Albert Einstein College of Medicine | 2009-12-01 |
| Pharmacokinetics of Lamivudine at Two Different Doses (NCT00985647) | Kirby Institute | 2009-12-01 |
| Medications for Chronic HIV: Education and Collaboration (NCT01038076) | Boston University | 2009-12-01 |
| Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals (NCT00865826) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-12-01 |
| Pilot Assessment of Lopinavir/Ritonavir and Maraviroc (NCT00981318) | Rodwick, Barry M., M.D. | 2009-12-01 |
| Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults (NCT01017536) | Aeras | 2009-12-01 |
| A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs) (NCT01106638) | Montefiore Medical Center | 2009-12-01 |
| Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 (NCT01009814) | ViiV Healthcare | 2009-11-23 |
| Safety Study of Maraviroc's Effect on Human Osteoclasts (NCT01428986) | National Center for Global Health and Medicine, Japan | 2009-11-01 |
| Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS (NCT00963235) | Pfizer | 2009-11-01 |
| Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort (NCT00795483) | Germans Trias i Pujol Hospital | 2009-11-01 |
| HIV Vaccine Study in HIV Positive Patients (NCT01071031) | PepTcell Limited | 2009-11-01 |
| Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz (NCT00944957) | University Hospital, Geneva | 2009-11-01 |
| A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) (NCT00959699) | Merck Sharp & Dohme LLC | 2009-11-01 |
| Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy (NCT00991224) | University of Pennsylvania | 2009-11-01 |
| Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults (NCT00991354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV (NCT01040039) | Rockefeller University | 2009-11-01 |
| Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé) (NCT00928187) | ANRS, Emerging Infectious Diseases | 2009-11-01 |
| Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients (NCT00946595) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-11-01 |
| Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers (NCT00982579) | Medical Research Council | 2009-11-01 |
| Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV (NCT00995241) | Germans Trias i Pujol Hospital | 2009-11-01 |
| An Expanded Safety Study of Dapivirine Gel 4759 in Africa (NCT00917891) | International Partnership for Microbicides, Inc. | 2009-11-01 |
| A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy (NCT01026727) | Myrexis Inc. | 2009-11-01 |
| Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers (NCT00981695) | Medical Research Council | 2009-11-01 |
| Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA) (NCT00977301) | Radboud University Medical Center | 2009-11-01 |
| Bone Mineral Density Substudy - An Ancillary Study to MTN-003 (NCT00729573) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients (NCT00978237) | Juan A. Arnaiz | 2009-10-01 |
| A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa (NCT00971230) | International AIDS Vaccine Initiative | 2009-10-01 |
| The Shang Ring: A Novel Male Circumcision Device for HIV Prevention (NCT00993811) | Weill Medical College of Cornell University | 2009-10-01 |
| Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects (NCT00966329) | Germans Trias i Pujol Hospital | 2009-10-01 |
| Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women (NCT00992017) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Efficacy and Safety of Varenicline Among HIV-infected Patients (NCT00918307) | ANRS, Emerging Infectious Diseases | 2009-10-01 |
| Computerized Cognitive Rehabilitation in Ugandan Children With HIV (NCT00926003) | Michigan State University | 2009-10-01 |
| Cell Phone Reminders Intervention (NCT01049568) | University of North Carolina, Chapel Hill | 2009-10-01 |
| Switch From Tenofovir to Raltegravir for Low Bone Mineral Density (NCT00939874) | St Vincent's Hospital, Sydney | 2009-10-01 |
| Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic (NCT00947271) | The Miriam Hospital | 2009-10-01 |
| Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens (NCT00994344) | Germans Trias i Pujol Hospital | 2009-10-01 |
| Artery Elasticity After Switch From Epzicom to Truvada (NCT00998582) | Hennepin Healthcare Research Institute | 2009-10-01 |
| Appropriate Timing of HAART in Co-infected HIV/TB Patients (NCT01014481) | Bamrasnaradura Infectious Diseases Institute | 2009-10-01 |
| Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac) (NCT01008813) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-10-01 |
| HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) (NCT01023620) | University of Texas Southwestern Medical Center | 2009-10-01 |
| Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth (NCT00992836) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV (NCT00983853) | Vertex Pharmaceuticals Incorporated | 2009-10-01 |
| Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load (NCT00959413) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-09-01 |
| Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts (NCT00951795) | Abbott RDx Cardiometabolic | 2009-09-01 |
| Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy (NCT00811421) | Hospital Clinic of Barcelona | 2009-09-01 |
| Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients (NCT00925795) | University Hospital for Infectious Diseases, Croatia | 2009-09-01 |
| Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection (NCT00959894) | University of North Carolina, Chapel Hill | 2009-09-01 |
| A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice. (NCT00976950) | Boehringer Ingelheim | 2009-09-01 |
| Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients (NCT00974285) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2009-09-01 |
| The Raltegravir and Ribavirin Pharmacokinetics (PK) Study (NCT00982553) | Imperial College London | 2009-09-01 |
| Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants (NCT00833482) | Bristol-Myers Squibb | 2009-09-01 |
| HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children (NCT00978068) | University of California, San Francisco | 2009-09-01 |
| The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients (NCT00974519) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2009-09-01 |
| Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1 (NCT00807443) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2009-09-01 |
| Effect of Rosuvastatin on Endothelial Function (NCT00986999) | University of Hawaii | 2009-09-01 |
| The Maraviroc Central Nervous System (CNS) Study (NCT00982878) | Imperial College London | 2009-09-01 |
| Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet (NCT00984971) | CONRAD | 2009-09-01 |
| Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART) (NCT00974454) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2009-09-01 |
| A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen (NCT00931463) | Kirby Institute | 2009-09-01 |
| Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya (NCT01001507) | University of California, San Francisco | 2009-09-01 |
| The St. Marys and The Mater Switch Study (NCT00981773) | Imperial College London | 2009-09-01 |
| Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection (NCT01009762) | Gitte Kronborg | 2009-09-01 |
| Bioequivalence Study of Didanosine in Children Treated for HIV (NCT00668356) | Assistance Publique - Hôpitaux de Paris | 2009-09-01 |
| Statin Therapy to Improve Atherosclerosis in HIV Patients (NCT00965185) | Massachusetts General Hospital | 2009-09-01 |
| Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration (NCT00944541) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-09-01 |
| Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART (NCT00719602) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2009-08-01 |
| Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring (NCT02920827) | International Partnership for Microbicides, Inc. | 2009-08-01 |
| A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects (NCT00833781) | Massachusetts General Hospital | 2009-08-01 |
| TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients (NCT00896051) | Janssen R&D Ireland | 2009-08-01 |
| Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults (NCT00961883) | HIV Vaccine Trials Network | 2009-08-01 |
| Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents (NCT00766597) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Integration of Family Planning and HIV Services in Tanzania (NCT00941876) | FHI 360 | 2009-08-01 |
| Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing (NCT00968188) | University of Illinois at Chicago | 2009-08-01 |
| Genotypic Resistant HIV Strains in Taiwan (NCT00954863) | National Taiwan University Hospital | 2009-08-01 |
| Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune (NCT00979420) | Boehringer Ingelheim | 2009-08-01 |
| Improving Latent Tuberculosis (TB) Diagnosis in Thai Children (NCT00947609) | SEARCH Research Foundation | 2009-08-01 |
| Preparing for Adolescent HIV Vaccine Trials in South Africa: (NCT00944879) | Desmond Tutu HIV Centre | 2009-08-01 |
| Nutritional Status Among naïve HIV Infected Patients and HIV Infected Patients Receiving Highly Active Antiretroviral Therapy (NCT01899157) | Thai Red Cross AIDS Research Centre | 2009-08-01 |
| Affect Management for Early Adolescents (NCT01197404) | Rhode Island Hospital | 2009-08-01 |
| Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People (NCT00959088) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-08-01 |
| Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women (NCT00705679) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Raltegravir Switch for Toxicity or Adverse Events (NCT00958100) | Catholic University of the Sacred Heart | 2009-08-01 |
| IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia (NCT00663234) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2009-08-01 |
| Trial Embedded in an Electronic Personal Medical Health Records (NCT00972348) | University of California, San Francisco | 2009-07-01 |
| Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue (NCT00855088) | University of North Carolina, Chapel Hill | 2009-07-01 |
| Molecular Biology of Anal Cancer in HIV-Positive Patients (NCT00952874) | University Hospital, Geneva | 2009-07-01 |
| Effect of Antacids on the Pharmacokinetics of Raltegravir (NCT00944307) | University of Colorado, Denver | 2009-07-01 |
| Genotype Based Personalized Prescription of Nevirapine (NCT00986063) | Surakameth Mahasirimongkol | 2009-07-01 |
| Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens (NCT01049204) | St Stephens Aids Trust | 2009-07-01 |
| Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants (NCT01222130) | University of North Carolina, Chapel Hill | 2009-07-01 |
| Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (NCT00822315) | ANRS, Emerging Infectious Diseases | 2009-07-01 |
| An Expanded Safety Study of Dapivirine Gel 4789 in Africa (NCT00917904) | International Partnership for Microbicides, Inc. | 2009-07-01 |